Physician profile
Brian A Raphael
NPI 1205121324
$10,897.56
in general payments reported to CMS, 2019-2025
34 companies · $1,680 in 2025
The $1,680 reported for 2025 was more than what 85% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $898 · 2020: $937 · 2021: $1,443 · 2022: $2,533 · 2023: $1,871 · 2024: $1,535 · 2025: $1,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,986 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,986.17 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,133.87 | 2019-2025 | |
| Janssen Biotech, INC. | $1,062.71 | 2019-2025 | Tremfya, Simponi Aria, Remicade |
| Leo Pharma INC. | $857.35 | 2019-2025 | Adbry |
| Genzyme Corporation | $701.03 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $645.32 | 2019-2025 | |
| Pfizer INC. | $630.71 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $528.18 | 2019-2025 | Dupixent |
| Amgen INC. | $501.37 | 2019-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $471.77 | 2019-2025 | Ilumya, Odomzo, Blu-U |
| Incyte Corporation | $382.12 | 2021-2025 | Opzelura, Opzelura |
| Dermavant Sciences, INC. | $366.91 | 2022-2024 | Vtama |
| Vyne Pharmaceuticals INC. | $359.77 | 2020-2021 | |
| Ucb, INC. | $344.89 | 2019-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $327.04 | 2019-2025 | Nemluvio, Dysport, Aklief |
| Lilly USA, LLC | $319.76 | 2019-2025 | Taltz, Ebglyss, Olumiant |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $228.55 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $178.50 | 2023-2025 | Zoryve |
| Biofrontera INC. | $175.59 | 2021-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Misonix INC | $96.66 | 2020-2021 | |
| Mimedx Group, INC. | $87.59 | 2024 | |
| Celgene Corporation | $80.79 | 2019 | |
| Organogenesis INC. | $80.34 | 2024-2025 | Simplimax |
| Organon LLC | $74.92 | 2025 | Vtama |
| Verrica Pharmaceuticals INC. | $40.18 | 2024 | Ycanth |
| Allergan, INC. | $35.38 | 2019-2020 | |
| Almirall LLC | $33.92 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $27.60 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.67 | 2022 | |
| Prugen, INC. Pharmaceuticals | $21.69 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $17.81 | 2022 | |
| Genentech USA, INC. | $16.90 | 2021 | |
| Merz North America, INC. | $15.99 | 2025 | |
| Botanix Sb INC | $15.17 | 2025 | Sofdra |
| Ascensia Diabetes Care US INC. | $13.51 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Raphael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.